QQ客服 官方微博 反馈留言

	Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
	Liu, Na; Wei, Lei; Huang, Li; Yu, Fei; Zheng, Weifan; Qin, Bingjie; Zhu, Dong-Qin; Morris-Natschke, Susan L.; Jiang, Shibo; Chen, Chin-Ho
刊名	JOURNAL OF MEDICINAL CHEMISTRY
	2016
卷号	59期号:8
ISSN号	0022-2623
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4288379
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liu, Na,Wei, Lei,Huang, Li,et al. Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus[J]. JOURNAL OF MEDICINAL CHEMISTRY,2016,59(8).
APA	Liu, Na.,Wei, Lei.,Huang, Li.,Yu, Fei.,Zheng, Weifan.,...&Xie, Lan.(2016).Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus.JOURNAL OF MEDICINAL CHEMISTRY,59(8).
MLA	Liu, Na,et al."Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus".JOURNAL OF MEDICINAL CHEMISTRY 59.8(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。